HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: April 7 – April 13, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In two cases brought by drug manufacturers challenging a New Mexico state law governing contract pharmacy arrangements, the plaintiffs filed notices of supplemental authority.
  • In a case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the court stayed the case pending resolution of two similar cases at the Sixth Circuit.
  • In two cases challenging a Mississippi state law governing contract pharmacy arrangements, the United States Court of Appeals for the Fifth Circuit affirmed the lower court’s denial of each plaintiff’s preliminary injunction.
  • A drug manufacturer filed a complaint against the government, arguing that the government’s (1) refusal to enforce findings from its proposed audits of covered entities and (2) determination regarding what constitutes a “patient” is unlawful.
  • A trade association of drug manufacturers filed a complaint to challenge a Washington state law governing contract pharmacy arrangements.
  • In a case brought by a drug manufacturer against the government, an intervenor filed an unopposed motion to intervene, [...]

    Continue Reading



This Week in 340B: March 31 – April 6, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy

  • In three consolidated cases brought by a trade association for drug manufacturers challenging a Louisiana state law governing contract pharmacy arrangements, the United States filed an Amicus Curiae brief in support of plaintiff appellant.
  • In a case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the plaintiff appealed the court’s order granting the defendant’s motion to dismiss, denying the plaintiff’s motion for preliminary Injunction as moot, and dismissing the case for failure to state a claim.
  • In two cases challenging an Oregon state law governing contract pharmacy arrangements, Intervenor Oregon Primary Care Association filed a cross-motion and response for summary judgment.
  • In two cases challenging a Rhode Island state law governing contract pharmacy arrangements, the American Hospital Association, 340B Health, Health Association of Rhode Island, and American Society of Health-System Pharmacists filed an amicus brief in the First Circuit in support of defendant appellee.
  • In a case brought by a drug manufacturer challenging a Rhode Island [...]

    Continue Reading



This Week in 340B: March 24 – March 30, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy

  • Drug manufacturers filed two separate suits to challenge a Washington state law governing contract pharmacy arrangements.
  • In one case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the plaintiff appealed the court’s order granting the defendant’s motion to dismiss.
  • In a second case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the court granted the defendant’s motion to dismiss, denied the plaintiff’s motion for preliminary Injunction as moot, and dismissed the case for failure to state a claim, and the plaintiff filed an appeal.
  • In four cases brought by drug manufacturers challenging a Utah law governing contract pharmacy arrangements, the plaintiffs filed responses to the court’s order to show cause.



This Week in 340B: March 17 – March 23, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Child Sites; Other

  • In a case against HRSA challenging its certification of a group of entities as 340B-eligible, the plaintiffs filed a motion for summary judgment.
  • In a case brought by a drug manufacturer challenging a New Mexico state law governing contract pharmacy arrangements, the government filed an answer to the plaintiff’s complaint.
  • In a case brought by a drug manufacturer challenging a New Mexico state law governing contract pharmacy arrangements, the plaintiffs filed a notice of supplemental authority.
  • In an appealed qui tam action alleging that various drug manufacturers failed to charge accurate ceiling prices to 340B Covered Entities, the appellate court issued an opinion reversing the district court’s dismissal for failure to state a claim and remanding the case for further proceedings.
  • In a case brought by a trade association for drug manufacturers challenging a Colorado state law governing contract pharmacy arrangements, the court issued an order denying the plaintiff’s motion for preliminary injunction and the plaintiff filed a notice [...]

    Continue Reading



This Week in 340B: March 10 – March 16, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case brought by a 340B covered entity to challenge the Exclusion Rule, the defendant filed its response to the covered entity plaintiff’s motion for summary judgment.
  • In a case by a covered entity against a drug manufacturer alleging breach of contract, the court granted the covered entity’s motion to remand back to state court for lack of subject matter jurisdiction.
  • In a case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the defendant filed a reply supporting review of the order denying a stay of discovery.
  • In a case brought by a trade association for drug manufacturers challenging an Oregon state law governing contract pharmacy arrangements, the defendants filed a reply supporting summary judgment.
  • In a case brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, the defendants filed a reply supporting summary judgment.
  • In a [...]

    Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm
U.S. News Law Firm of the Year 2022 Health Care Law